Your browser doesn't support javascript.
loading
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases.
Andrews, Mark D; Dack, Kevin N; de Groot, Marcel J; Lambert, Maja; Sennbro, Carl J; Larsen, Mogens; Stahlhut, Martin.
Afiliação
  • Andrews MD; Drug Design, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
  • Dack KN; Drug Design, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
  • de Groot MJ; Drug Design, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
  • Lambert M; Drug Design, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
  • Sennbro CJ; Drug Design, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
  • Larsen M; Drug Design, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
  • Stahlhut M; Skin Research, LEO Pharma Research & Early Development, 2750 Ballerup, Denmark.
J Med Chem ; 65(13): 8828-8842, 2022 07 14.
Article em En | MEDLINE | ID: mdl-35767390
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Interleucina-17 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Interleucina-17 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article